Sleep-Prolonging Effect of Memantine for Short Periods and Low Doses
Authors:
- 5 November 2021
- journal article
- research article
- Published by Springer Nature in Neuroscience and Behavioral Physiology
- p. 1-5
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Galantamine improves sleep quality in patients with dementiaActa Neurologica Belgica, 2015
- Efficacy and safety of memantine in patients with moderate-to-severe Alzheimer's disease: results of a pooled analysis of two randomized, double-blind, placebo-controlled trials in JapanExpert Opinion on Pharmacotherapy, 2014
- Interactions between NMDA and dopamine receptors: A potential therapeutic targetBrain Research, 2012
- Efficacy of Memantine for Agitation in Alzheimer’s Dementia: A Randomised Double-Blind Placebo Controlled TrialPLOS ONE, 2012
- Evaluation of the Impact of Memantine Treatment Initiation on Psychotropics Use: A Study from the French National Health Care DatabaseNeuroepidemiology, 2008
- Efficacy study of galantamine in possible Alzheimer's disease with or without cerebrovascular disease and vascular dementia in Thai patients: a slow-titration regimenInternational Journal Of Clinical Practice, 2006
- Pharmacokinetic study of memantine in healthy and renally impaired subjectsClinical Pharmacology & Therapeutics, 2006
- Memantine in Moderate-to-Severe Alzheimer's DiseaseNew England Journal of Medicine, 2003
- Memantine-induced dopamine release in the prefrontal cortex and striatum of the rat — a pharmacokinetic microdialysis studyEuropean Journal of Pharmacology, 1994
- Sleep Fragmentation in Patients From a Nursing HomeJournal of Gerontology, 1989